Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162,190,120
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
103,177,662
-
Shares change
-
+1,271,274
-
Total reported value, excl. options
-
$894,340,921
-
Value change
-
+$22,913,349
-
Put/Call ratio
-
164%
-
Number of buys
-
115
-
Number of sells
-
-119
-
Price
-
$8.67
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q3 2025
335 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q3 2025.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103,177,662 shares
of 162,190,120 outstanding shares and own 64% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15,194,563 shares), BlackRock, Inc. (12,773,053 shares), SHAH CAPITAL MANAGEMENT (11,811,780 shares), STATE STREET CORP (7,196,719 shares), Sanofi (6,880,481 shares), D. E. Shaw & Co., Inc. (4,274,079 shares), COATUE MANAGEMENT LLC (3,836,986 shares), GEODE CAPITAL MANAGEMENT, LLC (3,792,064 shares), UBS Group AG (3,516,203 shares), and BANK OF AMERICA CORP /DE/ (3,101,074 shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.